MXPA03004166A - Nuevos usos de combinaciones de agonistas de 5-ht1a e inhibidores de la recaptacion de serotonina. - Google Patents

Nuevos usos de combinaciones de agonistas de 5-ht1a e inhibidores de la recaptacion de serotonina.

Info

Publication number: MXPA03004166A
Authority: MX; Mexico
Prior art keywords: ht1a; combined; novel uses; novel
Prior art date: 2000-11-14

Application number

MXPA03004166A

Other languages

English (en)

Inventor

Gerd Bartoszyk

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-14

Filing date

2001-10-16

Publication date

2003-09-22

2001-10-16 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2003-09-22 Publication of MXPA03004166A publication Critical patent/MXPA03004166A/es

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Indole Compounds (AREA)

MXPA03004166A 2000-11-14 2001-10-16 Nuevos usos de combinaciones de agonistas de 5-ht1a e inhibidores de la recaptacion de serotonina. MXPA03004166A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00124815		2000-11-14
PCT/EP2001/011952 WO2002040024A1 (en)	2000-11-14	2001-10-16	Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors

Publications (1)

Publication Number	Publication Date
MXPA03004166A true MXPA03004166A (es)	2003-09-22

Family

ID=8170369

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03004166A MXPA03004166A (es)	2000-11-14	2001-10-16	Nuevos usos de combinaciones de agonistas de 5-ht1a e inhibidores de la recaptacion de serotonina.

Country Status (22)

Country	Link
US (1)	US20040082594A1 (es)
EP (1)	EP1333832B1 (es)
JP (1)	JP2004513924A (es)
KR (1)	KR20030059244A (es)
CN (1)	CN1222291C (es)
AR (1)	AR031335A1 (es)
AU (2)	AU2002215027B2 (es)
BR (1)	BR0115296A (es)
CA (1)	CA2428511C (es)
CZ (1)	CZ302484B6 (es)
DE (1)	DE60131675T2 (es)
ES (1)	ES2296820T3 (es)
HK (1)	HK1060697A1 (es)
HU (1)	HUP0302751A3 (es)
MX (1)	MXPA03004166A (es)
NO (1)	NO20032148D0 (es)
PL (1)	PL204331B1 (es)
RU (1)	RU2288719C2 (es)
SK (1)	SK287337B6 (es)
UA (1)	UA79583C2 (es)
WO (1)	WO2002040024A1 (es)
ZA (1)	ZA200304606B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10305739A1 (de) *	2003-02-11	2004-08-19	Merck Patent Gmbh	Benzofuranderivate
PL1701940T3 (pl)	2003-12-23	2008-11-28	H Lundbeck As	Pochodne 2-(1H-indolilosulfanylo)benzyloaminy jako SSRI
EP1732610A2 (en)	2004-03-26	2006-12-20	Baylor University	Targeted serotonin reuptake inhibitors
AR052308A1 (es)	2004-07-16	2007-03-14	Lundbeck & Co As H	Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
WO2006034788A1 (en) *	2004-09-28	2006-04-06	Merck Patent Gmbh	Combinations of n-(indolecarbonyl-)piperazine derivatives and serotonin reuptake inhibitors
AR054393A1 (es)	2005-06-17	2007-06-20	Lundbeck & Co As H	Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en)	2005-06-17	2009-12-08	H. Lundbeck A/S	2-(1H-indolylsulfanyl)-aryl amine derivatives
EP2068863B1 (en) *	2006-08-11	2010-12-15	DSM IP Assets B.V.	Ligustilide for the treatment of disorders of the central nervous system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4333254A1 (de) *	1993-09-30	1995-04-06	Merck Patent Gmbh	Piperidine und Piperazine
DE19512639A1 (de) *	1995-04-05	1996-10-10	Merck Patent Gmbh	Benzonitrile und -fluoride
DE19637237A1 (de) *	1996-09-13	1998-03-19	Merck Patent Gmbh	Piperazin-Derivate
DE19730989A1 (de) *	1997-07-18	1999-01-21	Merck Patent Gmbh	Piperazin-Derivate
AU5033899A (en) *	1998-07-20	2000-02-14	Merck Patent Gmbh	Biphenyl derivatives

2001
- 2001-10-16 ES ES01983555T patent/ES2296820T3/es not_active Expired - Lifetime
- 2001-10-16 CA CA002428511A patent/CA2428511C/en not_active Expired - Fee Related
- 2001-10-16 UA UA2003065408A patent/UA79583C2/uk unknown
- 2001-10-16 HU HU0302751A patent/HUP0302751A3/hu unknown
- 2001-10-16 EP EP01983555A patent/EP1333832B1/en not_active Expired - Lifetime
- 2001-10-16 RU RU2003115431/15A patent/RU2288719C2/ru not_active IP Right Cessation
- 2001-10-16 PL PL360310A patent/PL204331B1/pl not_active IP Right Cessation
- 2001-10-16 AU AU2002215027A patent/AU2002215027B2/en not_active Ceased
- 2001-10-16 JP JP2002542397A patent/JP2004513924A/ja active Pending
- 2001-10-16 US US10/416,573 patent/US20040082594A1/en not_active Abandoned
- 2001-10-16 BR BR0115296-3A patent/BR0115296A/pt not_active Application Discontinuation
- 2001-10-16 KR KR10-2003-7006473A patent/KR20030059244A/ko not_active Application Discontinuation
- 2001-10-16 DE DE60131675T patent/DE60131675T2/de not_active Expired - Lifetime
- 2001-10-16 MX MXPA03004166A patent/MXPA03004166A/es active IP Right Grant
- 2001-10-16 SK SK638-2003A patent/SK287337B6/sk not_active IP Right Cessation
- 2001-10-16 CN CNB018188591A patent/CN1222291C/zh not_active Expired - Fee Related
- 2001-10-16 WO PCT/EP2001/011952 patent/WO2002040024A1/en active IP Right Grant
- 2001-10-16 AU AU1502702A patent/AU1502702A/xx active Pending
- 2001-10-16 CZ CZ20031433A patent/CZ302484B6/cs not_active IP Right Cessation
- 2001-11-14 AR ARP010105299A patent/AR031335A1/es unknown
2003
- 2003-05-13 NO NO20032148A patent/NO20032148D0/no not_active Application Discontinuation
- 2003-06-12 ZA ZA200304606A patent/ZA200304606B/en unknown
2004
- 2004-05-25 HK HK04103692A patent/HK1060697A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP2004513924A (ja)	2004-05-13
PL360310A1 (en)	2004-09-06
ZA200304606B (en)	2004-09-13
CZ302484B6 (cs)	2011-06-08
CN1222291C (zh)	2005-10-12
DE60131675T2 (de)	2008-11-20
CA2428511A1 (en)	2002-05-23
HK1060697A1 (en)	2004-08-20
PL204331B1 (pl)	2010-01-29
SK287337B6 (sk)	2010-07-07
ES2296820T3 (es)	2008-05-01
EP1333832A1 (en)	2003-08-13
DE60131675D1 (de)	2008-01-10
WO2002040024A1 (en)	2002-05-23
HUP0302751A3 (en)	2007-06-28
AU1502702A (en)	2002-05-27
CN1474691A (zh)	2004-02-11
KR20030059244A (ko)	2003-07-07
CA2428511C (en)	2009-12-29
BR0115296A (pt)	2003-09-02
EP1333832B1 (en)	2007-11-28
NO20032148L (no)	2003-05-13
NO20032148D0 (no)	2003-05-13
HUP0302751A2 (hu)	2003-11-28
AU2002215027B2 (en)	2006-10-05
US20040082594A1 (en)	2004-04-29
AR031335A1 (es)	2003-09-17
RU2288719C2 (ru)	2006-12-10
UA79583C2 (en)	2007-07-10
CZ20031433A3 (cs)	2003-09-17
SK6382003A3 (en)	2003-11-04

Legal Events

Date	Code	Title
2008-12-18	FG	Grant or registration
2013-11-27	GD	Licence granted
2014-12-10	GD	Licence granted

Publication	Publication Date	Title
ZA200204020B (en)	2003-11-21	Use of anti-CTLA-4-antibodies.
ZA200205479B (en)	2003-12-31	Novel biarylcarboxamides.
MXPA03007093A (es)	2003-11-18	Nueva composicion.
MXPA03007043A (es)	2003-11-18	Nueva sal de succinato de o-desmetil-venlafaxina.
HK1055955A1 (en)	2004-01-30	Methanesulphonamido-benzofuran, preparation methodand use thereof as synthesis intermediate.
ZA200206198B (en)	2003-11-03	New aza-indolyl derivatives.
MXPA03009558A (es)	2004-02-12	Compuestos novedosos.
MXPA03007834A (es)	2003-12-08	Uso de agonistas inversos de gabaa, en combinacion con agonistas parciales del receptor de nicotina, estrogenos, moduladores selectivos de estrogenos o vitamina e, para el tratamiento de transtornos cognitivos.
ZA200307102B (en)	2004-09-13	The use of enmantiomeric pure escitalopram.
EG23361A (en)	2005-01-31	High utility tissue.
EP1254140A4 (en)	2003-03-12	SAFRAMYCIN-ECTEINASCIDIN SERIES COMPOUNDS, USES AND SYNTHESIS
MXPA03006603A (es)	2004-02-12	Agonista de subtipo de receptor 5-ht1a.
MXPA03009698A (es)	2004-01-29	Vacuna multivalente que comprende un antigeno vih y un antigeno vsh y/o un antigeno vph.
MXPA03007693A (es)	2003-12-04	Composicion para la piel.
MXPA03008139A (es)	2003-12-12	Fluoralcoxifenilsulfonilureas sustituidas.
HK1050610A1 (en)	2003-07-04	Microemulsion aerosol composition.
MXPA03001991A (es)	2003-06-24	Novedosas arilalcano-sulfonamidas.
MXPA03000914A (es)	2003-10-06	Sintesis de (r)-3-(4 -bromobencil) -1-(3, 5-diclorofenil) -5-yodo-3 -metil-1-h -imidazo[1, 2-a]imidazol -2-ona.
MXPA03007314A (es)	2003-12-04	Composicion para la piel para reducir aceites y grasa de la piel.
EG23378A (en)	2005-02-28	Composition.
MXPA03004166A (es)	2003-09-22	Nuevos usos de combinaciones de agonistas de 5-ht1a e inhibidores de la recaptacion de serotonina.
MXPA03004341A (es)	2003-08-19	Nuevo uso de combinaciones de agonsitas de 5-ht1a e inhibidores selectivos de la recaptacion de serotonina.
GB0104554D0 (en)	2001-04-11	New uses
HK1066022A1 (en)	2005-03-11	Use of 1,1,1,3,3-pentafluorobutan
MXPA01000464A (es)	2003-07-21	Composicion.